(Q37767061)

22 August 2017

1 reference

title

Regulation and dysregulation of fibrosis in skeletal muscle (English)

1 reference

22 August 2017

2

Pura Muñoz-Cánoves

1 reference

22 August 2017

Antonio L Serrano

1

1 reference

PubMed ID

20570674

22 August 2017

language of work or name

English

0 references

publication date

4 June 2010

1 reference

Experimental Cell Research

22 August 2017

1 reference

22 August 2017

316

1 reference

22 August 2017

18

1 reference

22 August 2017

3050-3058

1 reference

Strength at the extracellular matrix-muscle interface.

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Relation between myofibers and connective tissue during muscle injury repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Context matters: in vivo and in vitro influences on muscle satellite cell activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

uPA deficiency exacerbates muscular dystrophy in MDX mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Cellular and molecular mechanisms of fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Inflammatory processes in muscle injury and repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Decorin and biglycan expression is differentially altered in several muscular dystrophies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Decorin gene transfer promotes muscle cell differentiation and muscle regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Transcriptional and posttranscriptional regulation of the plasminogen activator system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

PlGF-MMP-9-expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Comparison of mouse matrix metalloproteinase 13 expression in free-electron laser and scalpel incisions during wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Matrix metalloproteinase-1 treatment of muscle fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Multifunctional roles of MT1-MMP in myofiber formation and morphostatic maintenance of skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Notch2 negatively regulates myofibroblastic differentiation of myoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Antifibrotic effects of suramin in injured skeletal muscle after laceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor (CTGF/CCN2), which induces their dedifferentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Loss of myostatin attenuates severity of muscular dystrophy in mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Myostatin does not regulate cardiac hypertrophy or fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Myostatin directly regulates skeletal muscle fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

The impact of sarcopenia and exercise training on skeletal muscle satellite cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Alterations in the TGFbeta signaling pathway in myogenic progenitors with age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Molecular aging and rejuvenation of human muscle stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Sca-1-expressing nonmyogenic cells contribute to fibrosis in aged skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

Premature aging in skeletal muscle lacking serum response factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.05.035

10.1016/J.YEXCR.2010.05.035

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20570674